DK159382A - Fremgangsmaade til fremstilling af somatostatinforbindelser - Google Patents
Fremgangsmaade til fremstilling af somatostatinforbindelser Download PDFInfo
- Publication number
- DK159382A DK159382A DK159382A DK159382A DK159382A DK 159382 A DK159382 A DK 159382A DK 159382 A DK159382 A DK 159382A DK 159382 A DK159382 A DK 159382A DK 159382 A DK159382 A DK 159382A
- Authority
- DK
- Denmark
- Prior art keywords
- loweralkyl
- benzyl
- loweralkoxy
- substituent
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/16—Somatostatin; related peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/254,010 US4360516A (en) | 1981-04-13 | 1981-04-13 | Modified D-retro cyclic hexapeptide somatostatin analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK159382A true DK159382A (da) | 1982-10-14 |
Family
ID=22962578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK159382A DK159382A (da) | 1981-04-13 | 1982-04-07 | Fremgangsmaade til fremstilling af somatostatinforbindelser |
Country Status (9)
Country | Link |
---|---|
US (1) | US4360516A (de) |
EP (1) | EP0063308B1 (de) |
JP (1) | JPS57179142A (de) |
AT (1) | ATE14439T1 (de) |
DE (1) | DE3264861D1 (de) |
DK (1) | DK159382A (de) |
ES (1) | ES8304068A1 (de) |
GR (1) | GR75544B (de) |
PT (1) | PT74720B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4427661A (en) * | 1982-07-30 | 1984-01-24 | Merck & Co., Inc. | Fluorinated cyclic hexapeptide somatostatin analogs |
CH655505B (de) * | 1982-08-24 | 1986-04-30 | ||
DE3303345A1 (de) * | 1983-02-02 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | Cyclische peptide mit somatostatin-wirkung |
US4508711A (en) * | 1983-04-18 | 1985-04-02 | American Cyanamid Company | Cyclic pentapeptide displaying somatostatin antagonism and method of treatment of mammals therewith |
US4522813A (en) * | 1983-10-27 | 1985-06-11 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
US4612302A (en) * | 1983-11-14 | 1986-09-16 | Brigham And Women's Hospital | Clinical use of somatostatin analogues |
US4612366A (en) * | 1985-06-17 | 1986-09-16 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
AU1194092A (en) * | 1991-02-06 | 1992-09-07 | Georgetown University | Receptor blocking peptides of fibroblast growth factor receptor |
DE69229436T2 (de) * | 1991-02-08 | 1999-11-25 | Biomeasure Inc | Verwendung von somatostatinanalogen zur behandlung von melanomen |
US5811512A (en) * | 1991-08-22 | 1998-09-22 | The Trustees Of The University Of Pennsylvania | Non-peptide peptidomimetics and related cyclic hexapeptides |
US5504069A (en) * | 1993-02-11 | 1996-04-02 | Biomeasure, Inc. | Inhibition of trauma-induced tumor growth |
US5597894A (en) * | 1995-06-05 | 1997-01-28 | The Louisiana State University Medical Center Foundation | Multi-tyrosinated somatostatin analogs |
US5770687A (en) * | 1995-06-07 | 1998-06-23 | Peptor Limited | Comformationally constrained backbone cyclized somatostatin analogs |
US6004928A (en) * | 1997-05-13 | 1999-12-21 | Biomeasure, Incorporated | Method of treating hyperlipidemia |
WO1998051331A1 (en) * | 1997-05-13 | 1998-11-19 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) | Somatostatin and somatostatin agonists for decreasing body weight |
AU8019798A (en) * | 1997-05-13 | 1998-12-08 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Method and compositions for treating hyperlipidemia and other conditions |
EP0980253B1 (de) * | 1997-05-13 | 2004-03-31 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x |
US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
CZ305160B6 (cs) | 2001-06-08 | 2015-05-27 | Ipsen Pharma S.A.S. | Chimérické somatostatin-dopaminové analogy |
KR20070108953A (ko) | 2003-04-22 | 2007-11-13 | 소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. | 펩타이드 벡터 |
KR101731655B1 (ko) | 2008-06-12 | 2017-05-11 | 입센 바이오이노베이션 리미티드 | 암 억제 방법 |
KR101642363B1 (ko) | 2008-06-12 | 2016-07-25 | 입센 바이오이노베이션 리미티드 | 신경내분비계 질환의 억제 |
GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
AU2014280847B2 (en) | 2013-06-13 | 2019-07-04 | Antisense Therapeutics Ltd | Combination therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7708136L (sv) * | 1976-08-02 | 1978-02-03 | Merck & Co Inc | Cykliska hexapeptider |
US4162248A (en) * | 1976-10-14 | 1979-07-24 | Merck & Co., Inc. | Somatostatin analogs |
LU78191A1 (de) * | 1977-09-28 | 1979-05-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen cyclopeptiden |
US4190648A (en) * | 1979-03-13 | 1980-02-26 | Merck & Co., Inc. | Peptides having somatostatin activity |
US4235886A (en) * | 1979-10-31 | 1980-11-25 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
NZ195303A (en) * | 1979-10-31 | 1984-10-19 | Merck & Co Inc | Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions |
-
1981
- 1981-04-13 US US06/254,010 patent/US4360516A/en not_active Expired - Fee Related
-
1982
- 1982-04-06 AT AT82102924T patent/ATE14439T1/de not_active IP Right Cessation
- 1982-04-06 EP EP82102924A patent/EP0063308B1/de not_active Expired
- 1982-04-06 DE DE8282102924T patent/DE3264861D1/de not_active Expired
- 1982-04-07 PT PT74720A patent/PT74720B/pt unknown
- 1982-04-07 DK DK159382A patent/DK159382A/da not_active Application Discontinuation
- 1982-04-07 GR GR67845A patent/GR75544B/el unknown
- 1982-04-08 ES ES511335A patent/ES8304068A1/es not_active Expired
- 1982-04-10 JP JP57059001A patent/JPS57179142A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
ATE14439T1 (de) | 1985-08-15 |
EP0063308A1 (de) | 1982-10-27 |
PT74720B (en) | 1985-01-08 |
PT74720A (en) | 1982-05-01 |
US4360516A (en) | 1982-11-23 |
ES511335A0 (es) | 1983-02-16 |
EP0063308B1 (de) | 1985-07-24 |
GR75544B (de) | 1984-07-27 |
JPS57179142A (en) | 1982-11-04 |
DE3264861D1 (en) | 1985-08-29 |
ES8304068A1 (es) | 1983-02-16 |
JPH0360839B2 (de) | 1991-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK159382A (da) | Fremgangsmaade til fremstilling af somatostatinforbindelser | |
ES8406429A1 (es) | "un metodo de preparacion de nuevas sulfonamidas sustituidas" nota: se solicita como divisional de la patente de invencion n 516.504. | |
DK165323C (da) | Thieno-triazolo-1,4-diazepino-2-carboxylsyreamider, fremgangsmaader til fremstilling af forbindelserne, forbindelserne til anvendelse ved fremstilling af laegemidler med paf-antagonistisk virkning samt farmaceutiske praeparater indeholdende forbindelserne | |
DK135791D0 (da) | 1h-imidazooe4,5-caaquinolin-4-amin, farmaceutisk praeparat indeholdende en saadan forbindelse og fremga ngsmaade til fremstilling af forbindelsen | |
IL80216A0 (en) | 3-vinyl-and 3-ethinyl-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
DK288287A (da) | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande | |
SE8503415D0 (sv) | Novel isoindolinyl-alkyl-piperazines | |
DE3266708D1 (en) | Pyridazinone derivatives, process for their preparation and their use as fungicides | |
SE7901510L (sv) | Halogensubstituerade merkaptoacylaminosyror | |
DK149270C (da) | Analogifremgangsmaade til fremstilling af beta-carbolin-3-carboxylsyrederivater | |
GB2015521A (en) | Pyrrolidin-2-one derivatives | |
DE69106386T2 (de) | Oxysulfonylcarbamate. | |
DK156563C (da) | Analogifremgangsmaade til fremstilling af carbacyklinderivater | |
KR830010101A (ko) | 티에닐과 벤조티에닐-t-부틸아미노페녹시프로파놀의 제조방법 | |
ES2101269T3 (es) | Nuevos derivados de 1-fenil-biciclo-(2.2.2)-octano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
FI854343A0 (fi) | Foerfarande foer framstaellning av 3-amino-2,3-dihydro-1-benzoxepinfoereningar. | |
DK87483D0 (da) | Fremgangsmade til fremstilling af vinyloge carboxamider | |
CH653840GA3 (en) | Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ATS | Application withdrawn |